Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1979 Jul;16(1):92–97. doi: 10.1128/aac.16.1.92

Effect of 5-Iodo-5′-Amino-2′,5′-Dideoxyuridine on Varicella-Zoster Virus In Vitro

Jeffrey P Iltis †, Tai-Shun Lin, William H Prusoff 1, Fred Rapp 2
PMCID: PMC352795  PMID: 224809

Abstract

The antiviral effect of the nucleoside analog 5-iodo-5′-amino-2′,5′-dideoxyuridine (AIU) was tested with three isolates of varicella-zoster virus (VZV). AIU concentrations of 10 to 800 μM (3.5 to 288 μg/ml) reduced the number of plaques produced by VZV-infected cells and cell-free VZV from approximately 30 to 95%. Smaller plaque size was also observed in the presence of AIU. AIU was less effective than arabinofuranosylthymine in reducing VZV-induced plaques since as little as 5 μg of arabinofuranosylthymine per ml completely blocked plaque formation by cell-free VZV. Toxicity assays with human diploid embryo fibroblast cells were also carried out. Drug concentrations as high as 800 μM were not toxic to human diploid embryo fibroblast cells as determined by radiolabeling of cell deoxyribonucleic acid, ribonucleic acid, and protein.

Full text

PDF
92

Images in this article

96Image
on p.96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvin A. M., Feldman S., Merigan T. C. Human leukocyte interferon in the treatment of varicella in children with cancer: a preliminary controlled trial. Antimicrob Agents Chemother. 1978 Apr;13(4):605–607. doi: 10.1128/aac.13.4.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aswell J. F., Gentry G. A. Cell-dependent antiherpesviral activity of 5-methylarabinosylcytosine, an intracellular ara-T donor. Ann N Y Acad Sci. 1977 Mar 4;284:342–350. doi: 10.1111/j.1749-6632.1977.tb21969.x. [DOI] [PubMed] [Google Scholar]
  3. Babiuk L. A., Meldrum B., Gupta V. S., Rouse B. T. Comparison of the antiviral effects of 5-methoxymethyl-deoxyuridine with 5-iododeoxyuridine, cytosine arabinoside, and adenine arabinoside. Antimicrob Agents Chemother. 1975 Dec;8(6):643–650. doi: 10.1128/aac.8.6.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bryson Y. J., Connor J. D. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside. Antimicrob Agents Chemother. 1976 Mar;9(3):540–543. doi: 10.1128/aac.9.3.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheng Y. C., Domin B. A., Sharma R. A., Bobek M. Antiviral action and cellular toxicity of four thymidine analogues: 5-ethyl-,5-vinyl-, 5-propyl-, and 5-allyl-2'- deoxyuridine. Antimicrob Agents Chemother. 1976 Jul;10(1):119–122. doi: 10.1128/aac.10.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cheng Y. C., Goz B., Neenan J. P., Ward D. C., Prusoff W. H. Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine. J Virol. 1975 May;15(5):1284–1285. doi: 10.1128/jvi.15.5.1284-1285.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Clercq E., Descamps J., Shugar D. 5-Propyl-2'-deoxyuridine: a specific anti-herpes agent. Antimicrob Agents Chemother. 1978 Mar;13(3):545–547. doi: 10.1128/aac.13.3.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Feldman S., Hughes W. T., Kim H. Y. Herpes zoster in children with cancer. Am J Dis Child. 1973 Aug;126(2):178–184. doi: 10.1001/archpedi.1973.02110190156009. [DOI] [PubMed] [Google Scholar]
  10. Gentry G. A., Aswell J. F. Inhibition of herpes simplex virus replication by araT. Virology. 1975 May;65(1):294–296. doi: 10.1016/0042-6822(75)90034-3. [DOI] [PubMed] [Google Scholar]
  11. Goz B., Prusoff W. H. Pharmacology of viruses. Annu Rev Pharmacol. 1970;10:143–170. doi: 10.1146/annurev.pa.10.040170.001043. [DOI] [PubMed] [Google Scholar]
  12. Hackstadt T., Mallavia L. P. Deoxypyrimidine nucleoside metabolism in varicella-zoster virus-infected cells. J Virol. 1978 Feb;25(2):510–517. doi: 10.1128/jvi.25.2.510-517.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iltis J. P., Oakes J. E., Hyman R. W., Rapp F. Comparison of the DNAs of varicella-zoster viruses isolated from clinical cases of varicella and herpes zoster. Virology. 1977 Oct 15;82(2):345–352. doi: 10.1016/0042-6822(77)90009-5. [DOI] [PubMed] [Google Scholar]
  14. Jamieson A. T., Subak-Sharpe J. H. Biochemical studies on the herpes simplex virus-specified deoxypyrimidine kinase activity. J Gen Virol. 1974 Sep;24(3):481–492. doi: 10.1099/0022-1317-24-3-481. [DOI] [PubMed] [Google Scholar]
  15. Meyers J. D. Congenital varicella in term infants: risk reconsidered. J Infect Dis. 1974 Feb;129(2):215–217. doi: 10.1093/infdis/129.2.215. [DOI] [PubMed] [Google Scholar]
  16. Miller R. L., Iltis J. P., Rapp F. Differential effect of arabinofuranosylthymine of the replication of human herpesviruses. J Virol. 1977 Sep;23(3):679–684. doi: 10.1128/jvi.23.3.679-684.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ogino T., Otsuka T., Takahashi M. Induction of deoxypyrimidine kinase activity in human embryonic lung cells infected with varicella-zoster virus. J Virol. 1977 Mar;21(3):1232–1235. doi: 10.1128/jvi.21.3.1232-1235.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. RAPP F., VANDERSLICE D. SPREAD OF ZOSTER VIRUS IN HUMAN EMBRYONIC LUNG CELLS AND THE INHIBITORY EFFECT OF LODODEOXYURIDINE. Virology. 1964 Mar;22:321–330. doi: 10.1016/0042-6822(64)90023-6. [DOI] [PubMed] [Google Scholar]
  19. Rashbaum S. A., Cozzarelli N. R. Mechanism of DNA synthesis inhibition by arabinosyl cytosine and arabinosyl adenine. Nature. 1976 Dec 16;264(5587):679–680. doi: 10.1038/264679a0. [DOI] [PubMed] [Google Scholar]
  20. Reboul F., Donaldson S. S., Kaplan H. S. Herpes zoster and varicella infections in children with Hodgkin's disease: an analysis of contributing factors. Cancer. 1978 Jan;41(1):95–99. doi: 10.1002/1097-0142(197801)41:1<95::aid-cncr2820410114>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  21. Renis H. E. 5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses. Antimicrob Agents Chemother. 1978 Apr;13(4):613–617. doi: 10.1128/aac.13.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rifkind D. The activation of varicella-zoster virus infections by immunosuppressive therapy. J Lab Clin Med. 1966 Sep;68(3):463–474. [PubMed] [Google Scholar]
  23. Sargent E. N., Carson M. J., Reilly E. D. Varicella pneumonia. A report of 20 cases, with postmortem examination in six. Calif Med. 1967 Aug;107(2):141–148. [PMC free article] [PubMed] [Google Scholar]
  24. Schmidt N. J., Lennette E. H. Improved yields of cell-free varicella-zoster virus. Infect Immun. 1976 Sep;14(3):709–715. doi: 10.1128/iai.14.3.709-715.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Triebwasser J. H., Harris R. E., Bryant R. E., Rhoades E. R. Varicella pneumonia in adults. Report of seven cases and a review of literature. Medicine (Baltimore) 1967 Sep;46(5):409–423. [PubMed] [Google Scholar]
  26. Whitley R. J., Soong S. J., Dolin R., Galasso G. J., Ch'ien L. T., Alford C. A. Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med. 1977 Aug 11;297(6):289–294. doi: 10.1056/NEJM197708112970601. [DOI] [PubMed] [Google Scholar]
  27. Williamson A. P. The varicella-zoster virus in the etiology of severe congenital defects. A survey of eleven reported instances. Clin Pediatr (Phila) 1975 Jun;14(6):553-5, 558-9. doi: 10.1177/000992287501400607. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES